Australia markets close in 2 hours 49 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
200.05+1.73 (+0.87%)
At close: 4:00PM EDT
200.48 +0.43 (0.21%)
After hours: 06:35PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 551.84B
Enterprise value 346.48B
Trailing P/E 26.37
Forward P/E 116.13
PEG ratio (5-yr expected) 11.53
Price/sales (ttm)7.76
Price/book (mrq)5.64
Enterprise value/revenue 36.95
Enterprise value/EBITDA 719.50

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-27.42%
S&P500 52-week change 331.83%
52-week high 3283.45
52-week low 3185.33
50-day moving average 3196.67
200-day moving average 3210.78

Share statistics

Avg vol (3-month) 32.26M
Avg vol (10-day) 32.24M
Shares outstanding 5259.11M
Implied shares outstanding 6N/A
Float 258.93M
% held by insiders 10.13%
% held by institutions 193.47%
Shares short (14 July 2021) 44.09M
Short ratio (14 July 2021) 41.6
Short % of float (14 July 2021) 41.58%
Short % of shares outstanding (14 July 2021) 41.58%
Shares short (prior month 14 June 2021) 44.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021

Profitability

Profit margin 29.80%
Operating margin (ttm)33.93%

Management effectiveness

Return on assets (ttm)12.63%
Return on equity (ttm)23.83%

Income statement

Revenue (ttm)6.68B
Revenue per share (ttm)25.76
Quarterly revenue growth (yoy)17.60%
Gross profit (ttm)3.64B
EBITDA 2.38B
Net income avi to common (ttm)1.99B
Diluted EPS (ttm)7.59
Quarterly earnings growth (yoy)-92.00%

Balance sheet

Total cash (mrq)6.71B
Total cash per share (mrq)25.86
Total debt (mrq)893.85M
Total debt/equity (mrq)9.72
Current ratio (mrq)4.61
Book value per share (mrq)35.49

Cash flow statement

Operating cash flow (ttm)2.12B
Levered free cash flow (ttm)1.1B